Opthea highlights latest phase 3 trials for sozinibercept
The molecule is being evaluated in 2 phase 3 clinical trials for wet AMD and is administered via intravitreal injection in combination with standard-of-care antiโVEGF-A therapy.
United States University Of Nevada Charlesc Wykoff Arshadm Khanani Veerals Sheth Reno School Of Medicine
Source: ophthalmologytimes.com